NCT03802487 - Study To Determine Bioavailability of Sotagliflozin in Healthy Male and Female Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 14, 2019

Primary Completion Date

March 28, 2019

Study Completion Date

March 28, 2019

Conditions

Type 2 Diabetes MellitusHealthy Subjects

Interventions

DRUG

Sotagliflozin (SAR439954)

"Pharmaceutical form: Tablet~Route of administration: Oral"

DRUG

14C-microtracer

"Pharmaceutical form: Solution for injection~Route of administration: Intravenous"

DRUG

Charcoal

"Pharmaceutical form: Granules for suspension~Route of administration: Oral"

Trial Locations (1)

Investigational site number 8260001, Nottingham